Table 2.
Household and individual characteristics of the 2017 epilepsy survey (Kitgum, Pader and Moyo districts)
| Kitgum | Pader | Kitgum & Pader | Moyo | |
|---|---|---|---|---|
| Household characteristics | ||||
| Number of households: n (%) | 142 (36.4) | 55 (14.1) | 197 (50.5) | 193 (49.5) |
| Median household size: n (IQR) | 6 (4–8) | 6 (4–8) | 6 (4–8) | 5 (3–7) |
| Agriculture as main activity: n (%) | 134 (94.4) | 54 (98.2) | 188 (98.9) | 184 (95.3) |
| Family history of death from epilepsy: n (%) | 15 (10.6) | 2 (3.36) | 17 (8.6) | 7 (3.6) |
| Age (years) at death of PWEa: median (IQR) | 16 (13–19) | 33 (22–44) | 16 (13–19) | 17 (14–28) |
| Study population | ||||
| Number of participants: n (%) | 861 (40.2) | 316 (14.8) | 1177 (55.1) | 961 (45.0) |
| Age: median (IQR) | 16 (8–29) | 17 (7–26) | 16 (7–28) | 16 (8–30) |
| Male gender: n (%) | 419 (50.5) | 163 (53.4) | 582 (51.3) | 442 (48.2) |
| Ivermectin use in 2017: n (%) | 716 (83.5) | 249 (79.6) | 965 (82.5) | 779 (81.2) |
| Age distribution (years): n (%) | ||||
| 0–9 | 258 (29.8) | 98 (31.0) | 356 (30.3) | 279 (29.0) |
| 10–19 | 260 (30.2) | 89 (28.2) | 349 (29.7) | 268 (27.9) |
| 20–29 | 131 (15.2) | 61 (19.3) | 192 (16.3) | 154 (16.0) |
| 30–39 | 77 (8.9) | 20 (6.3) | 97 (8.2) | 93 (9.7) |
| ≥ 40 | 135 (15.7) | 48 (15.2) | 183 (15.6) | 167 (17.9) |
| Confirmed persons with epilepsy | ||||
| Number of PWEa: | 83 | 29 | 112 | 46 |
| Male gender: n (%) | 49 (59.0) | 17 (58.6) | 66 (58.9) | 21 (45.7) |
| Female gender: n (%) | 34 (41.0) | 12 (41.4) | 46 (41.1) | 25 (54.3) |
| Age in years: median (IQR) | 19 (16–22) | 16 (14–18) | 18 (16–20) | 23 (15–36) |
| Age at seizure onset (years): median (IQR)b | 9 (7–12) | 8 (7–11) | 9 (7–12) | 10 (2–15) |
| Year of onset of seizures: median (IQR)b | 2007 (2005–2010) | 2010 (2009–2012) | 2008 (2006–2011) | 2009 (2000–2012) |
| Positive Ov16 test: n (%)c | 13 (27.7) | 8 (50.0) | 21 (33.3) | 16 (36.4) |
IQR Interquartile range
aPWE Persons with epilepsy, including those with nodding seizures
b27 missing
cOnly a limited number of persons were tested (test not available or participant declined to be tested)